Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to -$101000.0.

  • Utah Medical Products' Change in Inventory fell 5074.63% to -$101000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 4259.5%. This contributed to the annual value of -$587000.0 for FY2024, which is 18761.19% down from last year.
  • Utah Medical Products' Change in Inventory amounted to -$101000.0 in Q3 2025, which was down 5074.63% from -$633000.0 recorded in Q2 2025.
  • Over the past 5 years, Utah Medical Products' Change in Inventory peaked at $1.1 million during Q3 2022, and registered a low of -$633000.0 during Q2 2025.
  • Over the past 5 years, Utah Medical Products' median Change in Inventory value was -$67000.0 (recorded in 2024), while the average stood at $100631.6.
  • Per our database at Business Quant, Utah Medical Products' Change in Inventory surged by 49082.13% in 2022 and then crashed by 27235.29% in 2025.
  • Utah Medical Products' Change in Inventory (Quarter) stood at $324000.0 in 2021, then decreased by 11.11% to $288000.0 in 2022, then tumbled by 188.54% to -$255000.0 in 2023, then soared by 69.02% to -$79000.0 in 2024, then dropped by 27.85% to -$101000.0 in 2025.
  • Its Change in Inventory stands at -$101000.0 for Q3 2025, versus -$633000.0 for Q2 2025 and -$275000.0 for Q1 2025.